Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C17H24N6O4S.4H2O |
| Molecular Weight | 480.536 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.O.C[C@H]1SC[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(N)=O
InChI
InChIKey=LYTHVCBIYIODIA-UVZXXTSMSA-N
InChI=1S/C17H24N6O4S.4H2O/c1-9-15(25)22-12(7-28-9)16(26)21-11(5-10-6-19-8-20-10)17(27)23-4-2-3-13(23)14(18)24;;;;/h6,8-9,11-13H,2-5,7H2,1H3,(H2,18,24)(H,19,20)(H,21,26)(H,22,25);4*1H2/t9-,11+,12+,13+;;;;/m1..../s1
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C17H24N6O4S |
| Molecular Weight | 408.475 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
NS-3 (montirelin, CG 3703) is an analog of thyrotrophin releasing hormone (TRH). More potent and longer acting than TRH, CG-3703 produced beneficial effects in animal models of concussion-induced unconsciousness, cerebral ischemia, memory disruption, spontaneous convulsions in rats, narcolepsy, and spinal trauma. Given its efficacy in these models, the potential indications were broadened to include seizures, nerve trauma, cognitive dysfunction, and sleep apnea.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q01717 Gene ID: 25570.0 Gene Symbol: Trhr Target Organism: Rattus norvegicus (Rat) |
35.2 nM [Ki] | ||
Target ID: GO:0061526 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: Grünenthal (1997) Montirelin—A CNS Active TRH Analogue (Grünenthal GmbH, Aachen, Germany), pp 1–34. refernce retrieved from: http://jpet.aspetjournals.org/content/305/2/410.full
Curator's Comment: There are some evidences of Motirelin effectitivity on animal models: 1) two-week oral administration of CG-3703 (16 mg/kg) significantly reduced cataplexy and daytime sleep in canine narcolepsy http://www.ncbi.nlm.nih.gov/pubmed/10869884,9236248
2) Chronic intake of CNK-602A (NS-3, montirelin, CG 3703) in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in Spontaneously epileptic rats and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy. http://www.ncbi.nlm.nih.gov/pubmed/8603636
0.5 mg of montirelin administered over 14 days improved ratings of global clinical state in 73% of patients exhibiting “disturbances of consciousness”.
Route of Administration:
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 04:37:16 GMT 2023
by
admin
on
Sat Dec 16 04:37:16 GMT 2023
|
| Record UNII |
27MN0584ML
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
53297483
Created by
admin on Sat Dec 16 04:37:16 GMT 2023 , Edited by admin on Sat Dec 16 04:37:16 GMT 2023
|
PRIMARY | |||
|
27MN0584ML
Created by
admin on Sat Dec 16 04:37:16 GMT 2023 , Edited by admin on Sat Dec 16 04:37:16 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
ANHYDROUS->SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |